Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019-05-28 23:55 | 2019-05-28 | IDYA | IDEAYA Biosciences, Inc. | CANAAN X L.P. | 10% owner | Pharmaceutical Preparations | BUY | $10.00 | 400,000 | $4,000,000 | 2,660,713 | +17.7% |
| 2019-05-14 02:32 | 2019-05-13 | NXTC | NextCure, Inc. | CANAAN X L.P. | 10% owner | Pharmaceutical Preparations | BUY | $15.00 | 50,000 | $750,000 | 2,254,442 | +2.3% |
| 2018-05-31 00:25 | 2018-05-30 | ITRM | Iterum Therapeutics plc | CANAAN X L.P. | Director, 10% owner | Pharmaceutical Preparations | BUY | $13.00 | 506,656 | $6,586,528 | 1,733,170 | +41.3% |
| 2018-05-21 23:34 | 2018-05-17 | PTGX | Protagonist Therapeutics, Inc | CANAAN X L.P. | 10% owner | Pharmaceutical Preparations | SALE | $6.09 | 38,968 | $237,358 | 2,116,552 | -1.8% |
| 2018-05-17 00:16 | 2018-05-14 | PTGX | Protagonist Therapeutics, Inc | CANAAN X L.P. | 10% owner | Pharmaceutical Preparations | SALE | $6.42 | 164,747 | $1,058,368 | 2,155,520 | -7.1% |
| 2018-03-26 23:25 | 2018-03-23 | PTGX | Protagonist Therapeutics, Inc | CANAAN X L.P. | 10% owner | Pharmaceutical Preparations | SALE | $20.71 | 59,950 | $1,241,325 | 2,320,267 | -2.5% |
| 2018-03-23 00:33 | 2018-03-20 | PTGX | Protagonist Therapeutics, Inc | CANAAN X L.P. | 10% owner | Pharmaceutical Preparations | SALE | $20.61 | 39,518 | $814,399 | 2,380,217 | -1.6% |
| 2018-03-20 00:22 | 2018-03-16 | PTGX | Protagonist Therapeutics, Inc | CANAAN X L.P. | 10% owner | Pharmaceutical Preparations | SALE | $20.55 | 20,365 | $418,509 | 2,419,735 | -0.8% |
| 2018-03-15 23:55 | 2018-03-13 | PTGX | Protagonist Therapeutics, Inc | CANAAN X L.P. | 10% owner | Pharmaceutical Preparations | SALE | $20.66 | 13,155 | $271,768 | 2,440,100 | -0.5% |
| 2016-08-17 01:28 | 2016-08-16 | PTGX | Protagonist Therapeutics, Inc | CANAAN X L.P. | Director, 10% owner | Pharmaceutical Preparations | BUY | $12.00 | 583,333 | $6,999,996 | 2,453,255 | +31.2% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.